Enterprise Europe Network (Profile ID: TOBG20161219004)
A Bulgarian research institute has developed a permanent duck embryo cell line which has broad application in the biotechnological domain. It is a fit model for investigation and diagnostic activities related to biological cells, viruses, toxicological and immune diseases, as well as, vaccine production. The organisation is looking for industrial partners and seeks commercial agreement with technical assistance.
A Bulgarian research institute with more than 30 years of experience in conducting fundamental and applied research in the field of human and veterinary medicine, focused on morphology, cell biology, pathology (pathological and clinical aspects of infectious, non-infectious and parasitic diseases) and anthropology encompassing important health and demographic issues.
The Duck Embryo Cells line is described as a standard cell culture system, used in research and applied in biotechnological production. It is derived from normal cells of 14 day old duck embryos. The line has covered all requirements of the international standards for permanent cell lines. It is a suitable product for production of recombined virus vectors that present a basis of the vaccine therapy for some human or animal diseases, including flu viruses and mammalian viruses.
The organisation is looking for industrial partners and seeks commercial agreement with technical assistance, providing the necessary know-how and assuring technical assistance for adaptation to the needs of the client in terms of investigation, diagnostics or vaccine production.
For more information please contact Enterprise Europe Network Latvia.